Efficacy of a glucagon-like peptide-1 agonist and restrictive versus liberal oxygen supply in patients undergoing coronary artery bypass grafting or aortic valve replacement: study protocol for a 2-by-2 factorial designed, randomised clinical trial

INTRODUCTION: Coronary artery bypass grafting (CABG) and/or aortic valve replacement (AVR) are associated with risk of death, as well as brain, heart and kidney injury. Glucagon-like peptide-1 (GLP-1) analogues are approved for treatment of type 2 diabetes, and GLP-1 analogues have been suggested to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiberg, Sebastian, Kjaergaard, Jesper, Møgelvang, Rasmus, Møller, Christian Holdflod, Kandler, Kristian, Ravn, Hanne, Hassager, Christian, Køber, Lars, Nilsson, Jens Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573662/
https://www.ncbi.nlm.nih.gov/pubmed/34740932
http://dx.doi.org/10.1136/bmjopen-2021-052340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573662/
https://www.ncbi.nlm.nih.gov/pubmed/34740932
http://dx.doi.org/10.1136/bmjopen-2021-052340

Ejemplares similares